Amicus Brief Addresses PTAB Review of Obviousness-Type Double Patenting and Patent Term Issues Affecting Biotech ...

New Taipei City, Taiwan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing ...

“Biotech Showcase exists to ensure early-stage innovation is seen and heard,” said Sara Jane Demy, Founder and CEO of Demy-Colton. “This year, we welcomed 2,800 attendees, including 1,144 investors ...

This series of meetings of experts, organized under the auspices of the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology, will bring together ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

John F. Crowley is president and CEO of the Biotechnology Innovation Organization. Kendalle Burlin O’Connell is CEO and president of MassBio. As nearly 20,000 scientists, executives, investors, ...

HONG KONG--(BUSINESS WIRE)--Reynold Lemkins Group, a leading global investment firm focused on late-stage growth and frontier technologies, announced its significant cornerstone investment in the ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement sy ...

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that its chief ...

Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date. This series of meetings of experts, organized under the auspices of ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, 2026 /EINPresswire.com/ — As Demy-Colton ...

Claflin University is building a biotech innovation center to offer students hands-on experiences in emerging fields, backed by $17 million in federal funding.